FcγR and EGFR Polymorphisms as Predictive Markers of Cetuximab Efficacy in Metastatic Colorectal Cancer
Yuka InoueShoichi HazamaShigeyoshi IwamotoYasuhiro MiyakeChu MatsudaRyouichi TsunedomiNaoko OkayamaYuji HinodaTakahiro YamasakiYutaka SuehiroShigefumi YoshinoJunichi SakamotoHideyuki MishimaMasaaki Oka
Molecular Diagnosis & Therapy
18
5
541
548
10.1007/s40291-014-0103-6
https://doi.org/10.1007/s40291-014-0103-6https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000344623000007&DestApp=WOS_CPL